The epidemiology of 5-methoxy-N, N-dimethyltryptamine (5-MeO-DMT) use: Benefits, consequences, patterns of use, subjective effects, and reasons for consumption

Potential Therapeutic Effects of Psilocybin

(2017) Matthew W. Johnson et al.   Neurotherapeutics

The Challenging Experience Questionnaire: Characterization of challenging experiences with psilocybin mushrooms

(2016) Frederick S Barrett et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Modification of 5-methoxy-N,N-dimethyltryptamine-induced hyperactivity by monoamine oxidase A inhibitor harmaline in mice and the underlying serotonergic mechanisms

(2016) Xi-Ling Jiang et al.   Pharmacological Reports

Self-reported use of novel psychoactive substances in a US nationally representative survey: Prevalence, correlates, and a call for new survey methods to prevent underreporting

(2015) Joseph J. Palamar et al.   DRUG AND ALCOHOL DEPENDENCE

Psychedelic N,N-Dimethyltryptamine and 5-Methoxy-N,N-Dimethyltryptamine Modulate Innate and Adaptive Inflammatory Responses through the Sigma-1 Receptor of Human Monocyte-Derived Dendritic Cells

(2014) Attila Szabo et al.   PLoS One

Psychedelics and Mental Health: A Population Study

(2013) Teri S. Krebs et al.   PLoS One

Psychedelic 5-Methoxy-N,N-Dimethyltryptamine: Metabolism, Pharmacokinetics, Drug Interactions, and Pharmacological Actions

(2011) Hong-Wu Shen et al.   CURRENT DRUG METABOLISM

Indolealkylamines: Biotransformations and Potential Drug–Drug Interactions

(2008) Ai-Ming Yu   AAPS Journal

Hallucinogens as discriminative stimuli in animals: LSD, phenethylamines, and tryptamines

(2008) J. C. Winter   PSYCHOPHARMACOLOGY